EDN1 and systemic sclerosis: In the context of SSc, multiple studies have reported alterations in endothelial function, including decreased nitric oxide (NO) bioavailability, heightened endothelin-1 (ET-1) levels, and increased expression of adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1) and E-selectin.